John B Moriarty is Chief Legal Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 76,931 shares of RNA, which is worth approximately $5.45 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 26,824 shares (Common Stock) at a price of $71.87 per share, resulting in proceeds of $1,927,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 76.9K
61.1% 3M change
207.72% 12M change
Total Value Held $5.45 Million

John B Moriarty Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Payment of exercise price or tax liability
$1,927,840 $71.87 p/Share
26,824 Reduced 25.85%
76,931 Common Stock
Dec 17 2025
BUY
Grant, award, or other acquisition
-
56,000 Added 35.05%
103,755 Common Stock
Aug 04 2025
SELL
Open market or private sale
$81,291 $36.21 p/Share
2,245 Reduced 4.49%
47,755 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 33.33%
50,000 Common Stock
Aug 01 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock

Also insider at

OLMA
Olema Pharmaceuticals, Inc. Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
JBM

John B Moriarty

Chief Legal Officer
San Francisco, CA

Track Institutional and Insider Activities on RNA

Follow Avidity Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA